Hanyang University at ESGCT 2026
Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website
Hanyang University brings 3 presentations to ESGCT 2026 in Hamburg. Its work centres on non-viral nanocarriers for RNA medicines, including carrier-free and peptide-coated lipid systems aimed at acute lung injury. A separate strand delivers antagonists of microRNA-21 in vesicles to produce anti-tumour effects.
| Organization | ESGCT 2026 Attendance |
|---|---|
Hanyang University Seoul, South Korea | |
Poster Wed Oct 28 1:30pm–3:30pm Carrier-free drug nanoplatform for systemic delivery of anti-miR155 and curcumin in acute lung injury Poster Wed Oct 28 1:30pm–3:30pm Dual-targeted PEV delivery of miRNA-21 antagonists elicits anti-tumor effects Poster Thu Oct 29 2:00pm–4:00pm Gene delivery nanoplatform using peptide-coated lipid core micelles for treating acute lung injury |
Instantly find 20 buyers from Hanyang University
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction